乌鸦传媒

<乌鸦传媒 class="page-title">Endocrinology

Metabolic Syndrome

<乌鸦传媒 class="page-description">

More in Metabolic Syndrome

First Drug Approved for Familial Chylomicronemia Syndrome

Antisense oligonucleotide olezarsen slashes high triglycerides

Dec 20, 2024
FDA APPROVED olezarsen (Tryngolza) over a computer rendering of fats in the bloodstream.
Endocrinologist Deserts; U.S. Obesity Declines; New Obesity Definition Coming Soon

News and commentary from the endocrinology world

Dec 17, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Opinion
Are GLP-1 Drug Holidays a Risk Worth Taking?

Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care

Dec 08, 2024
image
Serious Outcomes of Steatotic Liver Disease Hit Men and Women Differently

Liver cancer risk higher among men, while cirrhosis more common in women

Dec 04, 2024
A computer rendering of a transparent female body with a fatty liver highlighted.
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up

News and commentary from the endocrinology world

Dec 03, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndrome

News and commentary from the endocrinology world

Nov 26, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?

News and commentary from the endocrinology world

Nov 19, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy

Most are eligible for weight management indication

Nov 18, 2024
AHA over a photo of McCormick Place Convention Center in Chicago, IL.
16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surge

News and commentary from the endocrinology world

Nov 12, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Patients With Obesity Shed Pounds With Drug-Free Capsule

Participants also had improved cardiometabolic measures with Epitomee device

Nov 08, 2024
ObesityWeek over a photo of Henry B. Gonz谩lez Convention Center in San Antonio, TX.
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years

Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist

Nov 07, 2024
ObesityWeek over a photo of Henry B. Gonz谩lez Convention Center in San Antonio, TX.
Early-Life Sugar Restriction Reduced Diabetes, Hypertension Risk

Diagnoses were also delayed the longer sugar was restricted

Nov 06, 2024
ObesityWeek over a photo of Henry B. Gonz谩lez Convention Center in San Antonio, TX.
CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down

News and commentary from the endocrinology world

Nov 05, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Weight Loss After Bariatric Surgery in Teens Persisted at 10 Years

Remission of coexisting conditions was also maintained, long-term data show

Oct 30, 2024
A photo of surgeons performing laparoscopic bariatric surgery.
More in Metabolic Syndrome

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

0.75 CME Credits
Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

0.50 CME Credits
Examining the Pathophysiology, Burden, and Evolving Treatment Landscape of Acromegaly

0.50 CME Credits
Enhancing Acromegaly Care Through Integration of the Latest Clinical Evidence and Patient-Centered Management

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment

0.50 CME Credits
Beyond Statin Therapy: Evidence-Based Strategies and Advanced Therapeutic Approaches to Hyperlipidemia Management

0.75 CME Credits
Aligning Clinical Practices With the Latest Evidence in Management of Comorbidities and Complications in People With Cystic Fibrosis